Hikma Pharmaceuticals USA Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 2 Esterbrook Lane, Cherry Hill, New Jersey (NJ) 08003, United States (USA)
- Operations here
- analysisapi manufacturelabelmanufacturepackrelabelrepacksalvage
- FDA identifiers
- FEI 2220525 · DUNS 946499746
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2026-05-13
- VAIDrug Quality Assurance2024-06-12
- VAIDrug Quality Assurance2023-11-03
- NAIDrug Quality Assurance2022-07-07
- VAIDrug Quality Assurance2019-09-10
- NAIDrug Quality Assurance2018-09-14
- NAIDrug Quality Assurance2017-04-04
- NAIDrug Quality Assurance2015-05-21
- NAIUnapproved and Misbranded Drugs2014-09-19
- NAIDrug Quality Assurance2014-05-01
- NAIDrug Quality Assurance2013-10-22
- VAIDrug Quality Assurance2013-06-14
- NAIDrug Quality Assurance2013-03-28
- NAIDrug Quality Assurance2012-10-24
- VAIDrug Quality Assurance2011-04-13
- VAIDrug Quality Assurance2010-10-29
- NAIDrug Quality Assurance2010-03-11
- VAIDrug Quality Assurance2009-03-10
Drugs this plant is listed as making
27 distinct drugs across 75 products name this site in their FDA label.
- Amikacin SulfateHikma Pharmaceuticals USA Inc.
- Bumetanidein shortageCivica, Inc.
- Dicyclomine HydrochlorideHikma Pharmaceuticals USA Inc.
- diphenhydramine hydrochlorideHikma Pharmaceuticals USA Inc.
- Doxapram hydrochlorideHikma Pharmaceuticals USA Inc.
- FamotidineHikma Pharmaceuticals USA Inc.
- Fentanyl Citratein shortageHikma Pharmaceuticals USA Inc.
- Fosphenytoin SodiumHikma Pharmaceuticals USA Inc.
- Heparin sodiumin shortageHikma Pharmaceuticals USA Inc.
- Ketorolac Tromethaminein shortageHikma Pharmaceuticals USA Inc.
- Lorazepamin shortageHikma Pharmaceuticals USA Inc.
- Meperidine Hydrochloridein shortageHikma Pharmaceuticals USA Inc.
- methocarbamolHikma Pharmaceuticals USA Inc.
- Midazolamin shortageHikma Pharmaceuticals USA Inc.
- morphine sulfatein shortageHikma Pharmaceuticals USA Inc.
- Nalxone HydrochlorideHikma Pharmaceuticals USA Inc.
- Neostigmine MethylsulfateHikma Pharmaceuticals USA Inc.
- OndansetronHikma Pharmaceuticals USA Inc.
- Phenobarbital SodiumHikma Pharmaceuticals USA Inc.
- Phenylephrine HydrochlorideHikma Pharmaceuticals USA Inc.
- Phenytoin SodiumHikma Pharmaceuticals USA Inc.
- Prochlorperazine EdisylateHikma Pharmaceuticals USA Inc.
- Promethazine Hydrochloridein shortageHikma Pharmaceuticals USA Inc.
- Sodium ChlorideHikma Pharmaceuticals USA Inc.
- Testosterone CypionateCipla USA Inc.
- Waterin shortageCivica, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.